KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


CEO of Alligator Bioscience on the company's BD strategies in immuno-oncology

Per Norlen, CEO of Alligator Bioscience, tells Scrip's Jo Shorthouse about the recent addition to the pipeline, and the next big milestones for the company, which develops immuno-oncology antibodies. Three years after a global licensing deal with Janssen, he shares his thoughts on the present landscape for partnering in IO therapies.

Get the latest news as it happens.